The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)July 22, 2026 — A group of Senate Democrats has renewed its push to remove marijuana from the federal list of controlled substances, taking a broader approach than the Trump administration’s ongoing effort to reclassify marijuana as a Schedule III drug. Whether or not this latest effort succeeds in changing the federal status of marijuana remains to be seen, and businesses like Tilray Brands Inc.
July 22, 2026 — Oncotelic Therapeutics (OTCQB: OTLC) ogether with Sapu Nano, announced publication of a peer-reviewed study in Biomedicines detailing the preclinical data supporting Sapu003, its intravenous Deciparticle(TM) formulation of everolimus. The publication outlines the program’s absorption, distribution, metabolism, excretion (“ADME”), pharmacokinetics, tissue distribution, GLP toxicology and cGMP manufacturing data, supporting the ongoing Phase 1 clinical evaluation of Sapu003 in patients with advanced solid tumors.
July 22, 2026 — NanoViricides, Inc. (NYSE American: NNVC) announced it has applied to the Democratic Republic of Congo’s regulatory agency for approval to begin a Phase II clinical trial evaluating its NV-387 Oral Gummies as a treatment for the current Bundibugyo ebolavirus outbreak.
July 22, 2026 — Olenox Industries (NASDAQ: OLOX) issued a shareholder letter from Chairman and CEO Mike McLaren outlining the company’s strategy to integrate natural gas production, electricity generation and AI-driven computing into a vertically integrated energy platform. McLaren said Olenox aims to capture greater value by converting its natural gas into electricity and directing that power toward its highest-value applications, including AI workloads, bitcoin mining, data infrastructure or grid sales during peak pricing periods, rather than relying solely on commodity wellhead pricing.
July 22, 2026 — A new study suggests that theratio of two common dietary fats may profoundly influence how well your immune system fights infection and cancer. Specifically, the balance between polyunsaturated and monounsaturated fats could alter the composition of immune cell membranes, making the cells more vulnerable to a destructive process called ferroptosis.
July 22, 2026 — Gold prices ticked up as the week started as diplomatic efforts to deescalate tensions in the Middle East between Tehran and Washington got underway. Prices of crude oil also declined.
July 22, 2026 — A recent poll conducted by Gallup has found that more than half of all employees in the U. S.
July 22, 2026 — Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.
July 22, 2026 — Kairos Pharma (NYSE American: KAPA) has entered into a strategic collaboration with Bayer to evaluate its lead antibody candidate, ENV-105 (carotuximab), in combination with Bayer’s XOFIGO(R) (radium-223 dichloride) for the treatment of metastatic castration-resistant prostate cancer involving bone. ENV-105 is a first-in-class CD105/BMP signaling inhibitor designed to overcome cancer drug resistance and is currently being evaluated in Phase 1 and Phase 2 clinical trials.
July 22, 2026 — Datavault AI (NASDAQ: DVLT) will host its first Analyst and Investor Day in New York City on Aug. 4, 2026, where management plans to outline the company’s strategic roadmap and demonstrate technologies supporting its AI-powered data monetization and real-world asset tokenization platform.
July 22, 2026 — American Fusion (OTC: AMFN) has appointed Alec Rossa as chief revenue officer, tasking the longtime executive with leading the company’s global commercial strategy as it advances development of its proprietary Texatron(TM) Fusion Engine(TM). Rossa will oversee customer development, strategic partnerships, government and institutional relationships and commercialization of the company’s planned Power-as-a-Service (“PaaS”) business model.
July 22, 2026 — This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.
July 22, 2026 — The company has received Scientific Advice from Germany’s Paul-Ehrlich-Institute (“PEI”) supporting the proposed development strategy for its lead BiTAC(R)-TCE program. The regulatory feedback provides early guidance on the company’s biological rationale, safety assessments, and non-clinical development plan, for its novel therapeutic platform.
July 21, 2026 — Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to home ownership, was recently added as a member of the Russell Microcap Index. An article discussing this highlights the notable milestone for Beeline as it joins a group of small-cap companies tracked by institutional investors and index-linked funds.
July 21, 2026 — Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.
July 21, 2026 — Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.
July 21, 2026 — VivoSim Labs, Inc. (NASDAQ: VIVS) announced it has entered into a securities purchase agreement with a single healthcare-focused institutional investor to raise approximately $4 million in gross proceeds through a private placement of 4,705,883 shares of common stock, or common stock equivalents, and accompanying warrants priced at a combined $0.
July 21, 2026 — Greenwich LifeSciences (NASDAQ: GLSI) provided an update on its Phase 3 FLAMINGO-01 trial evaluating GLSI-100, an immunotherapy designed to prevent breast cancer recurrence, announcing that the study’s Data Safety Monitoring Board recommended the trial continue without modification following its May 2026 review. The company also said regulatory authorities in the U.
July 21, 2026 — Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.
July 21, 2026 — The company has received a Texas DSHS Certificate of Registration for Industrial Radiation Machines, allowing research and development activities involving its registered Texatron(TM) Fusion Engine(TM) systems at Texas Tech University. The registration provides the principal regulatory authorization supporting the company’s planned engineering, prototype testing, and validation roadmap, under applicable Texas radiation control regulations.